Cargando…
Safety and Efficacy of the Preserflo(®) Microshunt in Refractory Glaucoma: A One-Year Study
Purpose: To evaluate the safety and efficacy of Preserflo(®) microshunt implantation in eyes with refractory glaucoma. Methods: In this retrospective study, a cohort of patients who underwent Preserflo(®) microshunt implantation between April 2019 and August 2020 for refractory glaucoma were evaluat...
Autores principales: | Majoulet, Alexandre, Scemla, Benjamin, Hamard, Pascale, Brasnu, Emmanuelle, Hage, Alexandre, Baudouin, Christophe, Labbé, Antoine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739914/ https://www.ncbi.nlm.nih.gov/pubmed/36498660 http://dx.doi.org/10.3390/jcm11237086 |
Ejemplares similares
-
PreserFlo MicroShunt® exposure: a case series
por: Bunod, Roxane, et al.
Publicado: (2021) -
Preliminary results of Preserflo Microshunt versus Preserflo Microshunt and Ologen implantation
por: Vastardis, Iraklis, et al.
Publicado: (2021) -
Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma
por: Ibarz Barberá, Marta, et al.
Publicado: (2022) -
PreserFlo™ MicroShunt Combined with Phacoemulsification versus PreserFlo™ MicroShunt as a Standalone Procedure in Patients with Medically Resistant Open-Angle Glaucoma
por: Fili, Sofia, et al.
Publicado: (2022) -
One-Year Outcomes of Preserflo(TM) MicroShunt Implantation versus Trabeculectomy for Pseudoexfoliation Glaucoma
por: Nobl, Matthias, et al.
Publicado: (2023)